SHSE:688016 (China)
Â
Class A
Â¥
174.88
(-3.12%)
Apr 26
Business Description
Shanghai Microport Endovascular Medtech Co Ltd
ISIN : CNE100003MJ5
Share Class Description:
SHSE:688016: Class ACompare
Compare
Traded in other countries / regions
688016.China IPO Date
2019-07-22Description
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 83 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 309.54 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 24.64 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36 | |||||
| 3-Year EBITDA Growth Rate | 32.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.2 | |||||
| 3-Year FCF Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 39.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.01 | |||||
| 9-Day RSI | 48.05 | |||||
| 14-Day RSI | 47.77 | |||||
| 6-1 Month Momentum % | -5.12 | |||||
| 12-1 Month Momentum % | -4.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.76 | |||||
| Quick Ratio | 10.09 | |||||
| Cash Ratio | 9.49 | |||||
| Days Inventory | 248.62 | |||||
| Days Sales Outstanding | 45.35 | |||||
| Days Payable | 59.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.32 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 52.4 | |||||
| Forward Dividend Yield % | 1.32 | |||||
| 5-Year Yield-on-Cost % | 1.27 | |||||
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | 1.33 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 76.45 | |||||
| Operating Margin % | 47.51 | |||||
| Net Margin % | 41.48 | |||||
| FCF Margin % | 31 | |||||
| ROE % | 21.97 | |||||
| ROA % | 19.13 | |||||
| ROIC % | 51.24 | |||||
| ROC (Joel Greenblatt) % | 140.59 | |||||
| ROCE % | 24.65 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.68 | |||||
| PE Ratio without NRI | 25.34 | |||||
| Price-to-Owner-Earnings | 33.83 | |||||
| PEG Ratio | 0.78 | |||||
| PS Ratio | 10.65 | |||||
| PB Ratio | 3.76 | |||||
| Price-to-Tangible-Book | 4.14 | |||||
| Price-to-Free-Cash-Flow | 34.45 | |||||
| Price-to-Operating-Cash-Flow | 22.74 | |||||
| EV-to-EBIT | 20.09 | |||||
| EV-to-EBITDA | 20.09 | |||||
| EV-to-Revenue | 9.72 | |||||
| EV-to-FCF | 31.34 | |||||
| Price-to-Projected-FCF | 2.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.01 | |||||
| Price-to-Graham-Number | 2.16 | |||||
| Price-to-Net-Current-Asset-Value | 4.88 | |||||
| Price-to-Net-Cash | 5.64 | |||||
| Earnings Yield (Greenblatt) % | 4.98 | |||||
| FCF Yield % | 2.54 | |||||
| Forward Rate of Return (Yacktman) % | 21.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Microport Endovascular Medtech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,187.204 | ||
| EPS (TTM) (Â¥) | 6.81 | ||
| Beta | 1.13 | ||
| Volatility % | 33.66 | ||
| 14-Day RSI | 47.77 | ||
| 14-Day ATR (Â¥) | 6.044554 | ||
| 20-Day SMA (Â¥) | 176.912 | ||
| 12-1 Month Momentum % | -4.22 | ||
| 52-Week Range (Â¥) | 147.01 - 210.3 | ||
| Shares Outstanding (Mil) | 82.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Microport Endovascular Medtech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Frequently Asked Questions
What is Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)'s stock price today?
The current price of SHSE:688016 is ¥174.88. The 52 week high of SHSE:688016 is ¥210.30 and 52 week low is ¥147.01.
When is next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)?
The next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is .
Does Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 1.32% (As of Today), Highest Dividend Payout Ratio of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) was 0.47. The lowest was 0.22. And the median was 0.3. The  Forward Dividend Yield % of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 1.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers